Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
22 Organizations awarded 'Best Workplaces for Women in Greater China 2022' by Great Place to Work 2022-03-30 19:53
Transcenta Announces Presentation of Preclinical Data of TST005 at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022-03-30 19:28
The 23rd CHINASHOP will be held at Shanghai on June 29th - July 1st 2022 2022-03-30 18:35
ERS electronic unveils the Next-Generation of its ADM330 with a new design and advanced features 2022-03-30 16:30
BioVaxys Expands Cancer Vaccine Platform 2022-03-30 16:02
TOMRA: Packaging makes the leap into the cycle 2022-03-30 15:00
Trina Solar breaks world record yet again by setting i-TOPCon cell efficiency at 25.5% 2022-03-30 13:44
Launch of the music video "Seeking Yue" showing the charm of the famous city - Shaoxing 2022-03-30 13:24
Xinhua Silk Road: Chinese-built highway in Angola completes to boost economic and trade prosperity 2022-03-30 13:02
LambdaTest closes $45 million in a venture round led by Premji Invest to scale its software test orchestration platform 2022-03-30 11:30
With a global operator-only round, OSlash is rewriting fundraising for SaaS startups 2022-03-30 11:15
Growatt makes available its new battery ready inverter 2022-03-30 10:46
First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights 2022-03-30 10:36
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market 2022-03-30 10:22
"Ningbo, Setting Sail to Embrace the World", an extensive global cross-media journalism campaign 2022-03-30 09:12
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes 2022-03-30 09:00
LOLC Finance wins two awards at the 9th edition of Global Brands Magazine Awards 2022-03-30 09:00
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China 2022-03-30 08:05
Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential 2022-03-30 08:00
Innovent Announced 2021 Annual Results 2022-03-30 08:00
1 371 372 373 374 375 1141